Ami Bavishi

Managing Director

Ami has over 15 years of biotech investor relations experience through both agency and corporate roles.

Prior to joining Gilmartin, Ami was the Executive Director of Investor Relations and Corporate Communications at Rallybio. Before that, Ami was the Director of Investor Relations at Aerie Pharmaceuticals. Ami spent the majority of her career in roles of increasing responsibility at Burns McClellan, a New York-based life science IR and PR firm, where she developed and managed public company IR programs for various biotechnology and specialty pharmaceutical clients, as well as oversaw several of the firm’s investor days. Outside of IR, Ami also spent a year in business development with UK Trade and Investment, where she was responsible for assisting US-based biotechnology and medical device companies understand the business opportunities that exist in the United Kingdom.

Ami has a Masters in Public Health from George Washington University and Bachelor’s in Biology from Duquesne University.

Interesting Facts About Ami

• Has been kickboxing for almost 10 years – it is usually where people can find her most days after work.
• Spent three years of her childhood in Kobe, Japan and still considers it to be home.
• Huge supporter of all women’s sports, especially women’s basketball.